Burlingame, California
United States
15
2022-11-17
15
2024-02-13
These are the the leading inventors for applications assigned to Corvus Pharmaceuticals, Inc.:
Corvus Pharmaceuticals, Inc. based in Burlingame, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
#2 | 2022-02-22 ✅ Patent 11,254,686 granted on 2022-02-22Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
#3 | 2021-08-19 ✅ Patent 12,174,192 granted on 2024-12-24Methods for detecting and treating cancers having adenosine pathway activation
#4 | 2021-08-19 ✅ Patent 12,116,635 granted on 2024-10-15Methods for detecting and treating cancers having adenosine pathway activation
#5 | 2021-08-19 ✅ Patent 11,859,007 granted on 2024-01-02Humanized anti-CD73 antibodies
#6 | 2021-07-22 ✅ Patent 12,351,644 granted on 2025-07-08ANTI-CD73 ANTIBODIES
#7 | 2021-05-27 ✅ Patent 12,023,337 granted on 2024-07-02Methods of treating cancer
#8 | 2021-03-04 ✅ Patent 11,266,649 granted on 2022-03-08Pharmaceutical formulations
#9 | 2020-09-24 ✅ Patent 11,040,040 granted on 2021-06-22Methods of treating cancer
#10 | 2019-12-12 ✅ Patent 11,008,314 granted on 2021-05-18Compounds and methods for modulating interleukin-2-inducible t-cell kinase
#11 | 2019-04-11 ✅ Patent 10,870,652 granted on 2020-12-22Compounds and methods for modulating bruton's tyrosine kinase
#12 | 2019-03-14 ✅ Patent 10,822,426 granted on 2020-11-03Humanized anti-CD73 antibodies
#13 | 2019-03-14 ✅ Patent 10,912,776 granted on 2021-02-09Methods of treating cancer
#14 | 2018-10-11 ✅ Patent 10,654,825 granted on 2020-05-19Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof
#15 | 2018-01-11 ✅ Patent 10,793,636 granted on 2020-10-06Anti-CD73 antibodies
Also check out Corvus Pharmaceuticals, Inc.'s (Burlingame, United States) applicant profile with 19 patent applications submitted.
307971 ⎘